Quick Answer: Ozempic (semaglutide) is not directly linked to muscle pain in clinical trials, though some patients report musculoskeletal discomfort potentially related to weight loss, body composition changes, or increased activity
In addition, we discuss the increase in the endogenous secretion of this hormone through various stimuli (e.g., carbohydrates, proteins, gut microbiota, bacteria-derived molecules, bile acids, lipids, fatty acids, polyphenols, etc.) or by the increase of GLP-1-producing cells, i.e., L-cells, which can be an appropriate approach for the management of diabetes
Sirvi et al., 1987), but increased in demented PD patients in a single study (Ruberg et al., 1986)
Hunger is lower, mood is stable, and the body responds well to calorie deficits
For most people, semaglutide (Wegovy) or tirzepatide (Zepbound) are the strongest options with the most clinical backing